401 related articles for article (PubMed ID: 16759811)
21. Cell line issues related to specific expression vectors: retrovirus vectors.
Morgan EM
Dev Biol Stand; 1992; 76():301-5. PubMed ID: 1478348
[TBL] [Abstract][Full Text] [Related]
22. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.
Thaler S; Schnierle BS
Mol Ther; 2001 Sep; 4(3):273-9. PubMed ID: 11545619
[TBL] [Abstract][Full Text] [Related]
23. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
24. Intracellular assembly and budding of the Murine Leukemia Virus in infected cells.
Houzet L; Gay B; Morichaud Z; Briant L; Mougel M
Retrovirology; 2006 Feb; 3():12. PubMed ID: 16472393
[TBL] [Abstract][Full Text] [Related]
25. Intracellular trafficking of retroviral vectors: obstacles and advances.
Anderson JL; Hope TJ
Gene Ther; 2005 Dec; 12(23):1667-78. PubMed ID: 16292352
[TBL] [Abstract][Full Text] [Related]
26. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Ghani K; Cottin S; Kamen A; Caruso M
Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of CD81 tetraspanin in human cells producing retroviral-based particles: tailoring vector composition.
Rodrigues AF; Guerreiro MR; Santiago VM; Dalba C; Klatzmann D; Alves PM; Carrondo MJ; Coroadinha AS
Biotechnol Bioeng; 2011 Nov; 108(11):2623-33. PubMed ID: 21656710
[TBL] [Abstract][Full Text] [Related]
28. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
29. Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae.
Morikawa Y; Goto T; Yasuoka D; Momose F; Matano T
J Virol; 2007 Sep; 81(18):9911-21. PubMed ID: 17609278
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the potential of retroviral gene vectors produced on yeast intracellular membranes.
Li G; Yin J; Ren X
Med Hypotheses; 2007; 68(2):463-4. PubMed ID: 17027175
[No Abstract] [Full Text] [Related]
31. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
[TBL] [Abstract][Full Text] [Related]
32. Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication.
Rizvi TA; Ali J; Phillip PS; Ghazawi A; Jayanth P; Mustafa F
Virology; 2009 Mar; 385(2):464-72. PubMed ID: 19157480
[TBL] [Abstract][Full Text] [Related]
33. Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system.
Dong J; Hunter E
Virology; 1993 May; 194(1):192-9. PubMed ID: 8386872
[TBL] [Abstract][Full Text] [Related]
34. High efficiency retroviral vectors that contain no viral coding sequences.
Yu SS; Kim JM; Kim S
Gene Ther; 2000 May; 7(9):797-804. PubMed ID: 10822307
[TBL] [Abstract][Full Text] [Related]
35. Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios.
Aucoin MG; Perrier M; Kamen AA
Biotechnol Bioeng; 2006 Dec; 95(6):1081-92. PubMed ID: 16952153
[TBL] [Abstract][Full Text] [Related]
36. Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.
Hettich E; Janz A; Zeidler R; Pich D; Hellebrand E; Weissflog B; Moosmann A; Hammerschmidt W
Gene Ther; 2006 May; 13(10):844-56. PubMed ID: 16421600
[TBL] [Abstract][Full Text] [Related]
37. A novel human suspension culture packaging cell line for production of high-titre retroviral vectors.
Chan LM; Coutelle C; Themis M
Gene Ther; 2001 May; 8(9):697-703. PubMed ID: 11406764
[TBL] [Abstract][Full Text] [Related]
38. From leading role to the backstage: mesenchymal stem cells as packaging cell lines for in situ production of viral vectors.
Silva FH; Nardi NB
Med Hypotheses; 2006; 67(4):922-5. PubMed ID: 16737782
[TBL] [Abstract][Full Text] [Related]
39. Production in Saccharomycescerevisiae of MS2 virus-like particles packaging functional heterologous mRNAs.
Legendre D; Fastrez J
J Biotechnol; 2005 May; 117(2):183-94. PubMed ID: 15823407
[TBL] [Abstract][Full Text] [Related]
40. Retroviral vector production in the National Gene Vector Laboratory at Indiana University.
Cornetta K; Matheson L; Ballas C
Gene Ther; 2005 Oct; 12 Suppl 1():S28-35. PubMed ID: 16231053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
